Roberto  Cuca net worth and biography

Roberto Cuca Biography and Net Worth

CFO of TELA Bio
Roberto Cuca has over 25 years of experience in the life sciences, beginning first as a pharmaceutical and device regulatory lawyer then moving into finance and operating roles of increasing responsibility in medical technology and biopharma companies. Before joining TELA Bio, Mr. Cuca was CFO of OraSure Technologies, Inc., where he acquired and integrated four novel technology companies and raised $95 million in equity capital. Prior to that, he was Chief Financial Officer of Trevena, Inc., which he helped take public and where he raised over $275 million in equity and debt capital. Mr. Cuca received an M.B.A. from The Wharton School of the University of Pennsylvania, a J.D. from Cornell Law School, and an A.B. from Princeton University. Mr. Cuca is also a CFA Charterholder.

What is Roberto Cuca's net worth?

The estimated net worth of Roberto Cuca is at least $442,855.80 as of October 24th, 2024. Mr. Cuca owns 155,388 shares of TELA Bio stock worth more than $442,856 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Cuca may own. Additionally, Mr. Cuca receives an annual salary of $674,780.00 as CFO at TELA Bio. Learn More about Roberto Cuca's net worth.

How old is Roberto Cuca?

Mr. Cuca is currently 56 years old. There are 6 older executives and no younger executives at TELA Bio. The oldest executive at TELA Bio is Mr. Gregory A. Firestone, Chief Commercial Officer, who is 65 years old. Learn More on Roberto Cuca's age.

What is Roberto Cuca's salary?

As the CFO of TELA Bio, Inc., Mr. Cuca earns $674,780.00 per year. The highest earning executive at TELA Bio is Mr. Antony Koblish, Co-founder, President, CEO & Director, who commands a salary of $1,030,000.00 per year. Learn More on Roberto Cuca's salary.

How do I contact Roberto Cuca?

The corporate mailing address for Mr. Cuca and other TELA Bio executives is 1 GREAT VALLEY PARKWAY SUITE 24, MALVERN PA, 19355. TELA Bio can also be reached via phone at 484-320-2930 and via email at [email protected]. Learn More on Roberto Cuca's contact information.

Has Roberto Cuca been buying or selling shares of TELA Bio?

Within the last three months, Roberto Cuca has bought $144,999.00 in TELA Bio stock. Most recently, on Thursday, October 24th, Roberto Cuca bought 64,444 shares of TELA Bio stock. The stock was acquired at an average cost of $2.25 per share, with a total value of $144,999.00. Following the completion of the transaction, the chief financial officer now directly owns 155,388 shares of the company's stock, valued at $349,623. Learn More on Roberto Cuca's trading history.

Are insiders buying or selling shares of TELA Bio?

During the last year, TELA Bio insiders bought shares 4 times. They purchased a total of 182,220 shares worth more than $409,995.00. During the last year, insiders at the sold shares 2 times. They sold a total of 391,700 shares worth more than $1,855,836.00. The most recent insider tranaction occured on October, 24th when CFO Roberto Cuca bought 64,444 shares worth more than $144,999.00. Insiders at TELA Bio own 6.0% of the company. Learn More about insider trades at TELA Bio.

Information on this page was last updated on 10/24/2024.

Roberto Cuca Insider Trading History at TELA Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/24/2024Buy64,444$2.25$144,999.00155,388View SEC Filing Icon  
11/14/2023Buy10,000$4.49$44,900.0062,371View SEC Filing Icon  
6/7/2022Buy15,000$5.50$82,500.0034,892View SEC Filing Icon  
12/1/2021Buy1,780$12.64$22,499.20View SEC Filing Icon  
11/29/2021Buy423$12.60$5,329.80View SEC Filing Icon  
See Full Table

Roberto Cuca Buying and Selling Activity at TELA Bio

This chart shows Roberto Cuca's buying and selling at TELA Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TELA Bio Company Overview

TELA Bio logo
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Read More

Today's Range

Now: $2.85
Low: $2.71
High: $2.96

50 Day Range

MA: $2.86
Low: $2.49
High: $3.14

2 Week Range

Now: $2.85
Low: $2.30
High: $7.84

Volume

1,625,652 shs

Average Volume

197,123 shs

Market Capitalization

$112.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99